94 related articles for article (PubMed ID: 18483367)
1. Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer.
Matsubara J; Yamada Y; Hirashima Y; Takahari D; Okita NT; Kato K; Hamaguchi T; Shirao K; Shimada Y; Shimoda T
Clin Cancer Res; 2008 May; 14(10):3022-9. PubMed ID: 18483367
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of epidermal growth factor receptors in gastric cancer: a survival analysis by Weibull model incorporating long-term survivors.
Jácome AA; Wohnrath DR; Scapulatempo Neto C; Carneseca EC; Serrano SV; Viana LS; Nunes JS; Martinez EZ; Santos JS
Gastric Cancer; 2014 Jan; 17(1):76-86. PubMed ID: 23455716
[TBL] [Abstract][Full Text] [Related]
3. The expression of epidermal growth factor receptor 1 and human epidermal growth factor receptor 2 based on tumor location affect survival in gastric cancer.
Li GC; Jia XC; Zhao QC; Zhang HW; Yang P; Xu LL; Pang FN; Sun JB
Medicine (Baltimore); 2020 May; 99(21):e20460. PubMed ID: 32481349
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor receptor I (IGF-IR) and vascular endothelial growth factor receptor 2 (VEGFR-2) are expressed on the circulating epithelial tumor cells of breast cancer patients.
Pizon M; Zimon DS; Pachmann U; Pachmann K
PLoS One; 2013; 8(2):e56836. PubMed ID: 23418605
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Increased EGFR and IGF-1R Signaling and Its Correlation with Socio-Epidemiological Features and Biological Profile in Breast Cancer Patients: A Study in Northern Brazil.
Silva Rocha F; da Silva Maués JH; Brito Lins Pereira CM; Moreira-Nunes CA; Rodriguez Burbano RM
Breast Cancer (Dove Med Press); 2021; 13():325-339. PubMed ID: 34054308
[TBL] [Abstract][Full Text] [Related]
6. EGFR and HER2 expression in cervical cancer patients in Ibadan, Nigeria.
Orekoya AA; Abdus-Salam AA; Oyesegun AR; Ntekim AI; Folasire AM; Okolo CA; Olabumuyi AA; Dada AA; Adenipekun AA
Ecancermedicalscience; 2023; 17():1607. PubMed ID: 38414930
[TBL] [Abstract][Full Text] [Related]
7. Predicting human epidermal growth factor receptor 2 status of patients with gastric cancer by computed tomography and clinical features.
Li Y; Dai WG; Lin Q; Wang Z; Xu H; Chen Y; Wang J
Gastroenterol Rep (Oxf); 2024; 12():goae042. PubMed ID: 38726026
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting IGF1R-mediated Survival Signaling in Head and Neck Cancer with the Peptidomimetic SSTN
Stueven NA; Beauvais DM; Hu R; Kimple RJ; Rapraeger AC
Cancer Res Commun; 2023 Jan; 3(1):97-108. PubMed ID: 36968227
[TBL] [Abstract][Full Text] [Related]
9. Repurposed Drugs in Gastric Cancer.
Araújo D; Ribeiro E; Amorim I; Vale N
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615513
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology and experimental verification based research into the effect and mechanism of Aucklandiae Radix-Amomi Fructus against gastric cancer.
Song S; Zhou J; Li Y; Liu J; Li J; Shu P
Sci Rep; 2022 Jun; 12(1):9401. PubMed ID: 35672352
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine Phosphorylation Profiling Revealed the Signaling Network Characteristics of CAMKK2 in Gastric Adenocarcinoma.
Najar MA; Arefian M; Sidransky D; Gowda H; Prasad TSK; Modi PK; Chatterjee A
Front Genet; 2022; 13():854764. PubMed ID: 35646067
[TBL] [Abstract][Full Text] [Related]
12. Research progress on exosomal proteins as diagnostic markers of gastric cancer (review article).
Su H; Ren W; Zhang D
Clin Exp Med; 2023 Jun; 23(2):203-218. PubMed ID: 35066729
[TBL] [Abstract][Full Text] [Related]
13. Insulin and the insulin receptor collaborate to promote human gastric cancer.
Saisana M; Griffin SM; May FEB
Gastric Cancer; 2022 Jan; 25(1):107-123. PubMed ID: 34554347
[TBL] [Abstract][Full Text] [Related]
14. Systematic Elucidation of the Mechanism of Quercetin against Gastric Cancer via Network Pharmacology Approach.
Yang L; Hu Z; Zhu J; Liang Q; Zhou H; Li J; Fan X; Zhao Z; Pan H; Fei B
Biomed Res Int; 2020; 2020():3860213. PubMed ID: 32964029
[TBL] [Abstract][Full Text] [Related]
15. A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer.
Wang K; Li E; Busuttil RA; Kong JC; Pattison S; Sung JJY; Yu J; El-Omar EM; Simpson JA; Boussioutas A
Ther Adv Med Oncol; 2020; 12():1758835920930359. PubMed ID: 32754227
[TBL] [Abstract][Full Text] [Related]
16. Advances in insulin-like growth factor biology and -directed cancer therapeutics.
Fettig LM; Yee D
Adv Cancer Res; 2020; 147():229-257. PubMed ID: 32593402
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics Analysis of Potential Key Genes in Trastuzumab-Resistant Gastric Cancer.
Yang G; Jian L; Lin X; Zhu A; Wen G
Dis Markers; 2019; 2019():1372571. PubMed ID: 31949544
[TBL] [Abstract][Full Text] [Related]
18. Prognostic importance of PTEN, EGFR, HER-2, and IGF-1R in gastric cancer patients treated with postoperative chemoradiation.
Benli Yavuz B; Koç M; Kozacıoğlu S; Kanyılmaz G; Aktan M
Turk J Med Sci; 2019 Aug; 49(4):1025-1032. PubMed ID: 31318186
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor-induced mesenchymal-epithelial transition factor activation leads to insulin-like growth factor 1 receptor inhibitor unresponsiveness in gastric cancer cells.
Liu R; Tang W; Han X; Geng R; Wang C; Zhang Z
Oncol Lett; 2018 Nov; 16(5):5983-5991. PubMed ID: 30333869
[TBL] [Abstract][Full Text] [Related]
20. The fasting blood glucose and long non-coding RNA SNHG8 predict poor prognosis in patients with gastric carcinoma after radical gastrectomy.
Lin Y; Hu D; Zhou Q; Lin X; Lin J; Peng F
Aging (Albany NY); 2018 Oct; 10(10):2646-2656. PubMed ID: 30299268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
